9 Mesenchymal features of a novel 27-gene algorithm associate with canonical tumor promoting signaling pathways which may identify therapeutic options for immunotherapy resistant patients

• Tyler Nielsen,
• Rob Seitz,
• Douglas Ross,
• David Hout,
• Brock Schweitzer

Affiliations

Tyler Nielsen

Oncocyte Corporation, Nashville, TN, USA

Rob Seitz

Oncocyte Corporation, Nashville, TN, USA

Douglas Ross

Oncocyte Corporation, Nashville, TN, USA

David Hout

Oncocyte Corporation, Nashville, TN, USA

Brock Schweitzer

Oncocyte Corporation, Nashville, TN, USA